Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Sorafenib is a multikinase inhibitor used for the treatment of uHCC 10 Two Phase III studies (SHARP and Asia-Pacific) demonstrated significant improvements in overall survival in Hepatocellular Carcinoma
Continue readingOur results provide firm evidence for the efficacy of the applied regimen, with close to 80% of pediatric liver cancer patients achieving complete remission at the end of treatment. The study linked
Continue reading“These results suggested that antineoplaston A10 may inhibit the growth of human hepatoma cells through the induction of apoptosis” Conventional oncology may have little to offer the liver
Continue reading